Taisho Pharmaceutical Holdings Co., Ltd.
TAISF · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,872,000 | $3,087,000 | $4,363,000 | -$1,902,000 |
| Dep. & Amort. | $10,597,000 | $7,289,000 | $6,952,000 | $6,716,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $7,725,000 | $4,202,000 | -$4,363,000 | $1,902,000 |
| Operating Cash Flow | $21,194,000 | $14,578,000 | $13,904,000 | $13,432,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30,597,000 | -$32,715,000 | $16,115,000 | -$33,115,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $215,474,000 | $248,189,000 | $232,074,000 | $265,189,000 |
| End Cash | $246,071,000 | $215,474,000 | $248,189,000 | $232,074,000 |
| Free Cash Flow | $21,194,000 | $14,578,000 | $13,904,000 | $13,432,000 |